tiprankstipranks
Nautilus Biotechnolgy (NAUT)
NASDAQ:NAUT
US Market
Holding NAUT?
Track your performance easily

Nautilus Biotechnolgy (NAUT) Ownership - Who Owns Nautilus Biotechnolgy?

122 Followers

Nautilus Biotechnolgy (NAUT) Ownership Overview

42.95%3.78%41.86%4.42%6.99%
42.95% Insiders
41.86% Other Institutional Investors
4.42% ETFs
6.99% Public Companies and
Individual Investors
The ownership structure of Nautilus Biotechnolgy (NAUT) stock is a mix of institutional, retail, and individual investors. Approximately 50.06% of the company’s stock is owned by Institutional Investors, 42.95% is owned by Insiders, and 6.99% is owned by Public Companies and Individual Investors.
The ownership structure of Nautilus Biotechnolgy (NAUT) stock is a mix of institutional, retail, and individual investors. Approximately 45.64% of the company’s stock is owned by Institutional Investors, 42.95% is owned by Insiders, and 4.42% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 25, 2024
Godwin Mary E.
Svp Operations
xxxxxxxxxxxxx
$134509
Sep 18, 2024
Godwin Mary E.
Svp Operations
xxxxxxxxxxxxx
$99750
Mar 11, 2024
Sujal M Patel
Ceo, President, And Secretary,director, >10% Owner
xxxxxxxxxxxxx
$41446
Mar 07, 2024
Sujal M Patel
Ceo, President, And Secretary,director, >10% Owner
xxxxxxxxxxxxx
$98870

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Sep 30, 2024
xxxxxxxxxxxxx
$650797

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
20,479,892Insider16.31%39,935,789
17,158,999Insider13.67%33,460,048
12,594,211Institution10.03%24,558,711
9,111,151Insider7.26%17,766,744
6,479,845Insider5.16%12,635,698
2,670,777Institution2.13%5,208,015
2,580,150Institution2.05%5,031,293
2,415,222Institution1.92%4,709,683
547,978Institution0.44%1,068,557
506,195Institution0.40%987,080

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,415,222Institution1.92%4,709,683
547,978Institution0.44%1,068,557
506,195Institution0.40%987,080
327,779Institution0.26%639,169
326,358Institution0.26%636,398
231,803Institution0.18%452,016
137,487Institution0.11%268,100
90,768Institution0.07%176,998
35,652Institution0.03%69,521
23,438Institution0.02%45,704

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,745,090Institution1.39%4,537,234
1,348,011Institution1.07%2,628,621
670,132Institution0.53%1,742,343
446,069Institution0.36%869,835
388,384Institution0.31%757,349
222,271Institution0.18%577,905
139,316Institution0.11%271,666
119,310Institution0.10%243,392
114,300Institution0.09%222,885
77,194Institution0.06%157,476

FAQ

Who Owns Nautilus Biotechnolgy (NAUT)?
According to the latest TipRanks data, approximately 41.86% of the company's stock is held by institutional investors, 42.95% is held by insiders, and 6.99% is held by retail investors.
    What percentage of Nautilus Biotechnolgy (NAUT) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 41.86% of Nautilus Biotechnolgy (NAUT) stock is held by institutional investors.
      What percentage of Nautilus Biotechnolgy (NAUT) stock is held by retail investors?
      According to the latest TipRanks data, approximately 6.99% of Nautilus Biotechnolgy (NAUT) stock is held by retail investors.
        Who owns the most shares of Nautilus Biotechnolgy (NAUT)?
        Parag Mallick owns the most shares of Nautilus Biotechnolgy (NAUT).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis